8 months ago
CYBN
AnalystsSumant KulkarniSumant Kulkarni's Stock Forecasts
AnalystsSumant Kulkarni
Analyst Ranking
Bottom 6%
#4327 out of 4560 analysts
Average Return
-10.32%
Win Rate
35%19 out of 54
Risk vs Reward
Poor
Good
Sumant Kulkarni's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sage Therapeutics IncSAGE | +157.05% | $30.01 | $77.14 | 2020-04-07 - 2021-04-08 | Strong Buy |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | +126.10% | $22.49 | $50.85 | 2018-03-26 - 2019-03-27 | Strong Buy |
Cervomed IncCRVO | +50.12% | $16.18 | $24.29 | 2024-02-14 - 2024-04-23 | Strong Buy |
Neurocrine Biosciences IncNBIX | +46.17% | $95.84 | $140.09 | 2023-05-03 - 2024-04-23 | Strong Buy |
Alder Biopharmaceuticals IncALDR | +39.03% | $13.58 | $18.88 | 2019-03-13 - 2019-10-21 | Strong Buy |
Sumant Kulkarni Analyst Color
Get additional color on Sumant Kulkarni's coverage of popular stocks
9 months ago
SAGE
10 months ago
CYBN
Sumant Kulkarni's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intra Cellular Therapies IncITCI | 3 | Strong Buy | $107.00 | +44.58% | Maintains | 2 days ago |
Cervomed IncCRVO | 2 | Strong Buy | $65.00 | +167.60% | Maintains | 17 days ago |
Stoke Therapeutics IncSTOK | 2 | Strong Buy | $21.00 | +86.67% | Maintains | a month ago |
Bioxcel Therapeutics IncBTAI | 4 | Strong Buy | $7.00 | +135.69% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $33.00 | +97.13% | Maintains | a month ago |
Cara Therapeutics IncCARA | 3 | Strong Buy | $10.00 | +1,314.43% | Maintains | 2 months ago |
Biogen IncBIIB | 10 | Strong Buy | $305.00 | +57.88% | Maintains | 2 months ago |
Annovis Bio IncANVS | 1 | Strong Buy | $36.00 | +203.03% | Initiates Coverage On | 4 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $150.00 | +7.07% | Reiterates | 5 months ago |
Zevra Therapeutics IncZVRA | 3 | Strong Buy | $20.00 | +336.68% | Reiterates | 8 months ago |
Cybin IncCYBN | 3 | Strong Buy | $5.00 | +1,308.45% | Reiterates | 8 months ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $50.00 | +506.06% | Maintains | 8 months ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | $1.11 | -14.62% | Downgrades | 8 months ago |
Sage Therapeutics IncSAGE | 3 | Hold | $21.00 | +62.16% | Downgrades | 9 months ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | $14.00 | +83.01% | Maintains | a year ago |
Clene IncCLNN | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Gh Research PLCGHRS | 2 | Strong Buy | $41.00 | N/A | Maintains | 2 years ago |
Quince Therapeutics IncQNCX | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 3 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Strong Buy | $20.00 | N/A | Maintains | 5 years ago |
Avexis IncAVXS | 1 | Hold | $120.00 | N/A | Maintains | 6 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.